🔥Telegram İfşa

This is so very cool. OncoAlert

So excited to share our recent publication on antibody-drug conjugates! Thank you Aditya Bardia, MD @MGHBreastOnc and Hematology/Oncology clinics editor Harold J. Burstein, MD, PhD, FASCO for this opportunity.

Really honored to be able to lead this important work! Huge thanks to my mentor @connors_md and collaborators Lauren Merz, Jessie (Stuart) Ross, MD, Linda Li, MD (she/her), Rachel Occhiogrosso Abelman, MD, Ann Woolley, Kara Fields, Jess Grandoni, Becky Baron, and Gyorgy Frendl! A true team effort 💪🏼

Check out this case report describing TRK inhibitor use in a patient with metastatic triple negative breast cancer and NTRK fusion that was just published in Therapeutic Advances in Medical Oncology! #bcsm #oncoalert journals.sagepub.com/doi/10.1177/17…

So excited to share our most recent work! @MGHBreastOnc Aditya Bardia, MD

Can't wait to share our work and learn from these abstracts! Looking forward to #ASCO23 this weekend.

Such an amazing experience presenting our work on ADC sequencing as a Poster Discussion at #ASCO23! Thank you for the fantastic mentorship and opportunity Aditya Bardia, MD @MGHBreastOnc.

Thank you for the great opportunity to talk about ADCs in HER2+ breast cancer!

Such a fantastic experience presenting AACR on this exciting collaboration! Mass General Cancer Center

So excited to for the opportunity to join ASCO TECAG this upcoming year! Can't wait to get started.

Belated post -- so grateful for the opportunity to attend #ASCO2024 and for such amazing mentorship and support! Looking forward to what comes next. @MGHBreastOnc Aditya Bardia, MD Beverly Moy Conquer Cancer, the ASCO Foundation